USPTO serial 97853098
CONTROLCHECK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 27, 2026
- Examiner
- XU, ELAINE YILIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CONTROLCHECK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ALEXANDRIA, VA, US
ALEXANDRIA, VA, US
ALEXANDRIA, VA, US
Alexandria, VA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory B. Phillips
Gregory B. Phillips KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic database recorded on computer media containing pharmaceutical, medical, healthcare, and life sciences information | ACTIVE | — |
| 035 | Electronic data collection, management, analysis for business purposes, namely, in the fields of medicine, healthcare, pharmaceuticals, and biotechnology; Business services provided to the medical, healthcare, pharmaceutical, and biotechnology industries, namely, the collection, reporting, and analysis of healthcare and pharmaceutical quality data for business purposes | ACTIVE | — |
| 042 | Data warehousing; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control, usage, compatibility, and interoperability standards in connection with supply chain management and inventory management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with supply chain and inventory management systems for pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for supply chain management of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for dispensing and administering pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for managing supply chain and inventory management systems for pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for use in data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data and information in the pharmaceutical, medical, healthcare and life sciences fields; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to tracking and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for dispensing pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for administering pharmaceuticals; Software as a service (SAAS) services featuring software for organizing supply chain and inventory management systems for pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by KitCheck, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named CONTROLCHECK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 27, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 5, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 5, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 12, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 29, 2025 | IUAF | USE AMENDMENT FILED | — |
| Dec 29, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 6, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 5, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 19, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 2, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 1, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 5, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 7, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 7, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 7, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 7, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 7, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 14, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 3, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 27, 2023 | NWAP | NEW APPLICATION ENTERED | — |